These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28556898)

  • 1. Hemoglobin Concentration Influences N-Terminal Pro B-Type Natriuretic Peptide Levels in Hospitalized Older Adults with and without Heart Failure.
    Lelli D; Antonelli Incalzi R; Pedone C
    J Am Geriatr Soc; 2017 Nov; 65(11):2369-2373. PubMed ID: 28556898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department.
    Gaggin HK; Chen-Tournoux AA; Christenson RH; Doros G; Hollander JE; Levy PD; Nagurney JT; Nowak RM; Pang PS; Patel D; Peacock WF; Walters EL; Januzzi JL;
    Am Heart J; 2017 Oct; 192():26-37. PubMed ID: 28938961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative Importance of History of Heart Failure Hospitalization and N-Terminal Pro-B-Type Natriuretic Peptide Level as Predictors of Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.
    Kristensen SL; Jhund PS; Køber L; McKelvie RS; Zile MR; Anand IS; Komajda M; Cleland JGF; Carson PE; McMurray JJV
    JACC Heart Fail; 2015 Jun; 3(6):478-486. PubMed ID: 26046842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro-brain natriuretic peptide is a useful marker to identify latent heart failure patients in older adults in a rural outpatient clinic.
    Hamagawa K; Kubo T; Nishimura K; Baba Y; Hirota T; Yamasaki N; Kitaoka H
    Geriatr Gerontol Int; 2017 Oct; 17(10):1648-1653. PubMed ID: 27860152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study.
    Ndumele CE; Matsushita K; Sang Y; Lazo M; Agarwal SK; Nambi V; Deswal A; Blumenthal RS; Ballantyne CM; Coresh J; Selvin E
    Circulation; 2016 Feb; 133(7):631-8. PubMed ID: 26746175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study.
    Eurlings LW; Sanders-van Wijk S; van Kraaij DJ; van Kimmenade R; Meeder JG; Kamp O; van Dieijen-Visser MP; Tijssen JG; Brunner-La Rocca HP; Pinto YM
    J Card Fail; 2014 Dec; 20(12):881-90. PubMed ID: 25175696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I-Preserve study.
    Jhund PS; Anand IS; Komajda M; Claggett BL; McKelvie RS; Zile MR; Carson PE; McMurray JJ
    Eur J Heart Fail; 2015 Aug; 17(8):809-17. PubMed ID: 25921853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis.
    Savarese G; Musella F; D'Amore C; Vassallo E; Losco T; Gambardella F; Cecere M; Petraglia L; Pagano G; Fimiani L; Rengo G; Leosco D; Trimarco B; Perrone-Filardi P
    JACC Heart Fail; 2014 Apr; 2(2):148-58. PubMed ID: 24720923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and echocardiographic characteristics of elderly hospitalized patients with high levels of NT-proBNP without clinical diagnosis of heart failure.
    Lelli D; Pedone C; Rossi FF; Incalzi RA
    Aging Clin Exp Res; 2014 Dec; 26(6):607-13. PubMed ID: 24781829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma level of N-terminal pro brain natriuretic peptide (NT-proBNP) in elderly population in Poland--the PolSenior Study.
    Nadrowski P; Chudek J; Grodzicki T; Mossakowska M; Skrzypek M; Wiecek A; Zdrojewski T; Kozakiewicz K
    Exp Gerontol; 2013 Sep; 48(9):852-7. PubMed ID: 23770107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echocardiography, natriuretic peptides, and risk for incident heart failure in older adults: the Cardiovascular Health Study.
    Kalogeropoulos AP; Georgiopoulou VV; deFilippi CR; Gottdiener JS; Butler J;
    JACC Cardiovasc Imaging; 2012 Feb; 5(2):131-40. PubMed ID: 22340818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anemia considerations when assessing natriuretic peptide levels in ED patients.
    Karakoyun I; Colak A; Arslan FD; Hasturk AG; Duman C
    Am J Emerg Med; 2017 Nov; 35(11):1677-1681. PubMed ID: 28587950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
    Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Pedretti RF; Lagioia R; Frigerio M; Catanzaro R; Oliva F
    Int J Cardiol; 2013 Oct; 168(3):2120-6. PubMed ID: 23395457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for in-hospital mortality of patients hospitalized for acutely decompensated heart failure.
    Dvornik Š; Zaninović Jurjević T; Jurjević N; Lekić A; Zaputović L
    Acta Clin Belg; 2018 Jun; 73(3):199-206. PubMed ID: 29207933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalized with acute heart failure: an APEX trial substudy.
    Chi G; Januzzi JL; Korjian S; Daaboul Y; Goldhaber SZ; Hernandez AF; Hull RD; Gold A; Cohen AT; Harrington RA; Gibson CM
    J Thromb Thrombolysis; 2017 Nov; 44(4):457-465. PubMed ID: 28905172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal B-type natriuretic peptide and the association with left ventricular diastolic function in a population at high risk of incident heart failure: results of the SCReening Evaluationof the Evolution of New-Heart Failure Study (SCREEN-HF).
    McGrady M; Reid CM; Shiel L; Wolfe R; Boffa U; Liew D; Campbell DJ; Prior D; Krum H
    Eur J Heart Fail; 2013 May; 15(5):573-80. PubMed ID: 23338855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: results of the SCReening Evaluation of the Evolution of New Heart Failure study (SCREEN-HF).
    McGrady M; Reid CM; Shiel L; Wolfe R; Boffa U; Liew D; Campbell DJ; Prior D; Stewart S; Krum H
    Int J Cardiol; 2013 Oct; 169(2):133-8. PubMed ID: 24080362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predictive value of plasma biomarkers in discharged heart failure patients: role of plasma NT-proBNP.
    Leto L; Testa M; Feola M
    Minerva Cardioangiol; 2016 Apr; 64(2):157-64. PubMed ID: 26373781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.